Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)
Taiwan
· Delayed Price · Currency is TWD 33.60
-0.20 (-0.59%)
Aug 15, 2025, 1:49 PM CST
Taiwan Bio Therapeutics Market Cap
Taiwan Bio Therapeutics has a market cap or net worth of 2.84 billion as of August 15, 2025. Its market cap has increased by 1.89% in one year.
Market Cap
2.84B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
33.60
Market Cap Chart
Since May 13, 2022, Taiwan Bio Therapeutics's market cap has increased from 1.93B to 2.84B, an increase of 47.20%. That is a compound annual growth rate of 12.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 2.84B | -19.69% |
| Dec 31, 2024 | 3.54B | 103.07% |
| Dec 29, 2023 | 1.74B | 7.86% |
| Dec 30, 2022 | 1.62B | -16.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 210.16B |
| PharmaEssentia | 169.30B |
| Bora Pharmaceuticals Co., LTD. | 98.29B |
| Lotus Pharmaceutical | 54.04B |
| Oneness Biotech | 33.96B |
| Lumosa Therapeutics | 27.69B |
| Polaris Group | 27.62B |
| Center Laboratories | 26.85B |